View in EDS

Tralokinumab Plus Topical Corticosteroids as Needed Provides Progressive and Sustained Efficacy in Adults with Moderate-to-Severe Atopic Dermatitis Over a 32-Week Period: An ECZTRA 3 Post Hoc Analysis.

Saved in:
Bibliographic Details
Title: Tralokinumab Plus Topical Corticosteroids as Needed Provides Progressive and Sustained Efficacy in Adults with Moderate-to-Severe Atopic Dermatitis Over a 32-Week Period: An ECZTRA 3 Post Hoc Analysis.
Authors: Silverberg, Jonathan I.1 jonathanisilverberg@gmail.com, Adam, David N.2,3,4, Zirwas, Matthew5, Kalia, Sunil6,7, Gutermuth, Jan8, Pinter, Andreas9, Pink, Andrew E.10, Chiricozzi, Andrea11,12, Barbarot, Sebastien13, Mark, Thomas14, Tindberg, Ann-Marie14, Weidinger, Stephan15
Source: American Journal of Clinical Dermatology. Jul2022, Vol. 23 Issue 4, p547-559. 13p.
Database: Academic Search Ultimate
Description
ISSN:11750561
DOI:10.1007/s40257-022-00702-2